SULT2A1 and polycystic ovary syndrome: Metabolic consequences of obesity and insulin resistance are more prevalent in obese PCOS patients than non-obese ones, however, an increase in adrenal axis activity and DHEAS level is significantly more prevalent in non- obese patients.